Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |